Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Mellett

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Pharmaceutics|July 2, 2021
Protamine-Based Strategies for RNA TransfectionNatalia Teresa Jarzebska, Mark Mellett, Julia Frei, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2024
Design and Synthesis of Circular RNA Expression VectorsJulia Frei, Natalia T Jarzebska, Mark Mellett, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2024
A Basic Method for Formulating mRNA-Lipid Nanoparticle Vaccines in the LabNatalia T Jarzebska, Julia Frei, Mark Mellett, et al.
European Journal of Immunology|February 3, 2011
A poxviral homolog of the Pellino protein inhibits Toll and Toll-like receptor signallingBryan D Griffin, Mark Mellett, Antonio Campos-Torres, et al.
The British Journal of Dermatology|October 27, 2023
Role of the NLRP1 inflammasome in skin cancer and inflammatory skin diseasesLaura Calabrese, Zeno Fiocco, Mark Mellett, et al.
Biomedicines|November 27, 2025
Notable Differences in Clinical Features and Inflammatory Gene Expression Between Genital Lichen Sclerosus and Lichen PlanusPatrick Poffet, Veronika Baghin, Fabienne Fröhlich, et al.
Nature Communications|March 27, 2015
Orphan receptor IL-17RD regulates Toll-like receptor signalling via SEFIR/TIR interactionsMark Mellett, Paola Atzei, Ronan Bergin, et al.
FEBS Letters|January 12, 2005
Expression and subcellular targeting of canine parvovirus capsid proteins in baculovirus-transduced NLFK cellsLeona Gilbert, Outi Välilehto, Sanna Kirjavainen, et al.
Nature Communications|October 11, 2012
Orphan receptor IL-17RD tunes IL-17A signalling and is required for neutrophiliaMark Mellett, Paola Atzei, Alan Horgan, et al.
Anti-Cancer Drugs|July 16, 2024
Differential functionality of fluoropyrimidine nucleosides for safe cancer therapyTim Holzinger, Julia Frei, Natalia Teresa Jarzebska, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Pharmaceutics|July 2, 2021
Protamine-Based Strategies for RNA TransfectionNatalia Teresa Jarzebska, Mark Mellett, Julia Frei, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2024
Design and Synthesis of Circular RNA Expression VectorsJulia Frei, Natalia T Jarzebska, Mark Mellett, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2024
A Basic Method for Formulating mRNA-Lipid Nanoparticle Vaccines in the LabNatalia T Jarzebska, Julia Frei, Mark Mellett, et al.
European Journal of Immunology|February 3, 2011
A poxviral homolog of the Pellino protein inhibits Toll and Toll-like receptor signallingBryan D Griffin, Mark Mellett, Antonio Campos-Torres, et al.
The British Journal of Dermatology|October 27, 2023
Role of the NLRP1 inflammasome in skin cancer and inflammatory skin diseasesLaura Calabrese, Zeno Fiocco, Mark Mellett, et al.
Biomedicines|November 27, 2025
Notable Differences in Clinical Features and Inflammatory Gene Expression Between Genital Lichen Sclerosus and Lichen PlanusPatrick Poffet, Veronika Baghin, Fabienne Fröhlich, et al.
Nature Communications|March 27, 2015
Orphan receptor IL-17RD regulates Toll-like receptor signalling via SEFIR/TIR interactionsMark Mellett, Paola Atzei, Ronan Bergin, et al.
FEBS Letters|January 12, 2005
Expression and subcellular targeting of canine parvovirus capsid proteins in baculovirus-transduced NLFK cellsLeona Gilbert, Outi Välilehto, Sanna Kirjavainen, et al.
Nature Communications|October 11, 2012
Orphan receptor IL-17RD tunes IL-17A signalling and is required for neutrophiliaMark Mellett, Paola Atzei, Alan Horgan, et al.
Anti-Cancer Drugs|July 16, 2024
Differential functionality of fluoropyrimidine nucleosides for safe cancer therapyTim Holzinger, Julia Frei, Natalia Teresa Jarzebska, et al.
Pageof 4